- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Ipilimumab – November 2012
Ipilimumab, concentrate solution for I.V. infusion, 50 mg in 10mL, 200 mg in 40 mL, Yervoy®
Last updated
8 November 2023